Nanosonics: A clean story

Morgans
Although the FY15 results were slightly behind our forecasts, the result had been well flagged to the market. With a direct sales force in the US now fully established we expect to see a substantially stronger FY16. A growing global need/requirement for high level disinfection will support long term growth. A key short term catalyst expected 1H16 will be a set of guidelines published in Scotland and England recommending the use of automated validated decontamination systems, similar to the guidelines released in Wales. (NAN, ADD, Price Target A$1.99) Report attached, here is the link to the blog site: (VIEW LINK)
1 topic
1 stock mentioned

Senior Analyst at Morgans covering healthcare, life science, telecommunications, technology and media. I've spent the last twenty years investing in and researching emerging companies and have developed a wide network of contacts across these...
Expertise
No areas of expertise
Please sign in to comment on this wire.